ALPHAGAN brimonidine tartrate 2mg/mL eye drop bottle, Abbvie Pty Ltd, CON-1231
Product name
ALPHAGAN brimonidine tartrate 2mg/mL eye drop bottle
Sponsor name
Abbvie Pty Ltd
Consent start
Consent no.
CON-1231
Duration
The consent is effective from 23 April 2024 until 1 May 2025.
Standard
Paragraph 8(1)(i) of Therapeutic Goods Order No. 91 - Standard for labels of prescription and related medicines
Non-compliance with standard
The products do not have the current sponsor name and address on the label. The details on the label are for the previous sponsor Allergan Australia Pty. Ltd. whilst the current sponsor is AbbVie Pty Ltd.
Conditions imposed
The current risk mitigations strategies included in the application regarding contacting the sponsor will remain in place for the length of the exemption. This includes the website redirection as well as retaining the current customer service number that is included on the label.
Import, Supply, &/or Export
import and supply
Therapeutic product type
Prescription medicines